PhaseLite is a patented extract of Phaseolus vulgaris.
In the longest human study on PhaseLite, the white kidney bean extract shows potential for lowering body fat and reducing food cravings. Ingredient distributor Pharmachem (Kearny, NJ) says its findings, now published in the journal Obesity, give new insight into how the ingredient may lower body weight.
For 12 weeks, 123 subjects supplemented with PhaseLite or a placebo daily. Those consuming the bean extract incurred more weight loss and higher reductions in body fat mass and waist circumference, meaning the weight loss was due to loss of fat and not muscles. A complementary eating questionnaire indicated that PhaseLite users had less desire to eat and less craving for sweets.
By monitoring all subjects for 24 weeks, the researchers determined that a majority of PhaseLite users (74%) maintained their new body weight for an additional 12 weeks.
New review from BAPP estimates adulteration of five popular botanicals
September 10th 2024The study focused on the adulteration of black cohosh rhizome, echinacea root or herb, elder berry, ginkgo leaf, and turmeric root/rhizome. The authors reviewed 78 publications with a total of 2995 samples. Of the 2995 samples, 818 were reported to be adulterated or mislabeled.
PLT Health Solution's Bosewellia serrata extract granted updated license by Health Canada
August 27th 2024The Natural and Non-Prescription Health Products Directorate (NNPHD) of Health Canada has granted PLT Health Solutions an updated license to market its AprèsFlex 5-Day Joint Support Ingredient in Canada.